Category: Translation & Commercialisation
I started writing this post to provoke a conversation and scratch the surface on an important issue. There are many differing points of view and most are valid, and less valid at the same time depending on the lens you are looking through. Measuring impact from research requires a more sophisticated or complex conversation than […]VIEW POST
Written by Jenny Pyke Jenny is the R&D Program Advisor and Accreditation Manager with the National Association of Testing Authorities, Australia (NATA) There are ongoing discussions regarding the lack of reproducibility of research. This concern, expressed globally, has been fuelled by stakeholders’ failed attempts to reproduce key research outcomes and the retraction of some research papers, […]VIEW POST
Join a conversation with philanthropists, researchers, industry and government. Delivering impact from medical research.
In order to harness the benefits from medical research it is important to bring all key stakeholders together, including philanthropy, industry, government and academia. NFMRI’s conference uniquely provides this opportunity, creating an interactive forum to discuss opportunities, issues and ideas. We encourage delegates to submit questions in advance and contribute to the conversation. The […]VIEW POST
The ‘halo effect’ can be both a positive and negative for funders of research. How does it affect you?
A challenge for funders of research is that it often requires more than research to achieve their ultimate goals. Restricting funding to research is often set out in the terms of; a bequest, a donation, a grant, the constitution and may be a requirement for the funder to maintain charitable status. The outcome funders wish […]VIEW POST
Author: AusBiotech Innovation in biotechnology is a foundation stone of the future, providing solutions to human and animal disease, climate change, fuel alternatives and food security, as well as improving our quality of life. Australia is a global hub for biotechnology researchers, companies, investors and partners, which is strengthened by innovation-focussed policies and a not-to-be […]VIEW POST
Written by Dr Geoff Garrett AO FTSE, Chief Scientist of Queensland. SCIENCE VISION Winston Churchill: “The further backward you can look, the further forward you can see”. Steve Jobs: “You can’t connect the dots looking forward; you can only connect them looking backwards”. The Human Genome Project, completed in 2003, took 13 years and cost $2.7 billion. […]VIEW POST
Could this be a reality? We all know that not all good ideas gain traction and become reality. This is true for inventors, for business, for things around the home and for medical research. Discoveries and good ideas that are never disclosed and disappear without a trace may later be rediscovered and lead to future […]VIEW POST
Integrated Technology Research Platforms: Delivering Quality Outcomes for Academic and Industry Researchers
Written by Professor Ian Smith, Monash University Vice-Provost (Research and Research Infrastructure), A number of universities across the globe are recognising the value of Investment in world-class research infrastructure in the form of technology research platforms (TRP’s). These investments are helping to take research and industry collaborations to a new level and also helps create local […]VIEW POST
Written by Jarred Shein M. H. Carnegie & Co. The Federal Government provides around $2bn a year of cash and/or tax offset incentives to Australian-based companies that are engaged in research and development (R&D) through the R&D tax incentive program. Our belief is that the Government can potentially provide the innovation sector with greater funding, […]VIEW POST
We have previously written about our excellent academic research capability and that our biotechnology sector is rated 4th in the world. We have also lamented that our ability to connect our early research with impact and commercial opportunities is languishing well behind the OECD and other countries as reported in the Global Innovation Index. In […]VIEW POST